A new technology to reprogramme human cells into various cells developed by Fate Therapeutics has been granted patent in US.

Prostvac-VF, a therapeutic vaccine to treat prostate cancer by Bavarian Nordic, has been found prolonging the survival of patients with metastatic cancer.

Balaglitazone (DRF 2593), an investigative drug to treat diabetes cuts down HbA1c levels significantly, according to Dr. Reddy's and Rheoscience, the developers of the drug.

STA-9090, an experimental treatment against advanced gastrointestinal stromal tumours (GIST) has been shown encouraging results, according to Synta Pharmaceuticals Corp.

4.7 million doses of nasal spray version of H1N1 swine flu vaccine by AstraZeneca P.L.C.'s MedImmune unit have been recalled in US because tests showed a decline in potency.

India has decided to boost pharmaceutical trade with Russia along with other sector like energy, IT and communications, as part of the countries' efforts of strengthen bilateral relations.

Long acting version of testosterone undecanoate injection Aveed to boost the sexual libido in men needs more data to establish its safety, US FDA has said to Endo Pharmaceuticals, the developer of the drug.

Lambert Eaton Myasthenic Syndrome is a rare disorder that affects 4-10 in million

Generic drug market in Central and Eastern Europe jumped to €17.2bn in 2008, accounting for around 58% of the pharmaceutical market in the region in terms of value.

Avastin, the much-hyped block-buster anti-cancer therapy from Roche has been rejected by as treatment against colorectal cancer.